Lumakras Coupons & Savings Card – Discount Prices from $23575.30

The survival rate for Lumakras (sotorasib) can vary depending on several factors, including the specific type and stage of cancer being treated, as well as individual patient characteristics. Lumakras is primarily used for treating non-small cell lung cancer (NSCLC) with a specific KRAS G12C mutation. Clinical trials have shown that Lumakras can lead to a significant reduction in tumor size and progression-free survival in some patients. However, exact survival rates can differ, and it is important for patients to discuss their individual prognosis and treatment outcomes with their healthcare provider.

The cost of Lumakras can vary depending on factors such as insurance coverage, pharmacy, and location. On average, the monthly cost without insurance can be several thousand dollars. It is recommended to check with a specific pharmacy or insurance provider for the most accurate and up-to-date pricing information.

Lumakras (sotorasib) is not classified as a traditional chemotherapy drug. It is a targeted therapy used to treat certain types of non-small cell lung cancer (NSCLC) with a specific genetic mutation known as KRAS G12C. Targeted therapies like Lumakras work by specifically targeting cancer cells with this mutation, which can lead to fewer side effects compared to traditional chemotherapy.

Lumakras is used for the treatment of adults with non-small cell lung cancer (NSCLC) that has a specific mutation in the KRAS G12C gene. It is typically prescribed for patients whose cancer has progressed after receiving at least one prior systemic therapy.

Yes, sotorasib can be considered expensive. The cost of this medication can vary depending on factors such as insurance coverage, location, and healthcare provider. Patients are encouraged to discuss the cost and potential financial assistance options with their healthcare provider or pharmacist.